perugu_vada Posted July 12, 2020 Report Share Posted July 12, 2020 Some 4,000 people have so far registered to take part in coronavirus vaccination trials at Germany's University Hospital in Tübingen, near the southwestern city of Stuttgart. "It's a real luxury situation, unlike usual clinical trials," study director Peter Kremsner told the dpa news agency. "Normally we have trouble coming up with enough test subjects." A clinical study began in mid-June to test the tolerability of a vaccine developed by the German biopharmaceutical company CureVac. Since then, around 50 people have received the drug. According to Kremsner, no surprising side effects have yet been noticed. Quote Link to comment Share on other sites More sharing options...
-1.thumb.png.613bdd33b4e8b5f69ac815bf90e62a8b.png)
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.